GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Recommendation of “Hold” from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have received a consensus rating of “Hold” from the fourteen ratings firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $92.50.

GEHC has been the subject of several recent research reports. Jefferies Financial Group increased their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Barclays increased their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Citigroup increased their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Norges Bank acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $596,024,000. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares during the period. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $533,655,000. Capital Research Global Investors grew its stake in GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after buying an additional 4,998,154 shares during the last quarter. Finally, Cynosure Group LLC raised its holdings in GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after acquiring an additional 4,344,817 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $78.13 on Wednesday. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $89.77. The company’s fifty day simple moving average is $82.20 and its 200-day simple moving average is $78.54. The firm has a market cap of $35.61 billion, a PE ratio of 17.13, a P/E/G ratio of 1.76 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same period in the previous year, the business earned $1.45 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.